The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Constellation Pharmaceuticals Inc. | COM | 210373106 | 45,338 | 1,574,229 | SH | SOLE | 0 | 1,574,229 | 0 | ||
Revolution Medicines Inc | COM | 76155X100 | 27,120 | 685,011 | SH | SOLE | 0 | 685,011 | 0 | ||
RAPT Therapeutics Inc | COM | 75382E109 | 2,872 | 145,401 | SH | SOLE | 0 | 145,401 | 0 | ||
NGM Biopharmaceuticals Inc | COM | 62921N105 | 39,357 | 1,298,908 | SH | SOLE | 0 | 1,298,908 | 0 | ||
Nurix Therapeutics Inc | COM | 67080M103 | 22,565 | 686,274 | SH | SOLE | 0 | 686,274 | 0 |